Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Exploiting ban on 344...

    Exploiting ban on 344 FDC drugs, wholesalers dump non banned medicines

    Written by Geeta Sharma Sharma Published On 2016-04-22T13:38:57+05:30  |  Updated On 22 April 2016 1:38 PM IST
    Exploiting  ban on 344 FDC drugs, wholesalers dump non banned medicines

    Peethaambaran: The state of Kerala seems to be facing tremendous pressures due to the Health Ministry’s ban of 344 FDC drugs. The worst hit being the small scale pharma and contract manufacturers of the state; who are facing the brunt of the state’s wholesaler wrath in the form of having to accept non banned stocks along with the banned 344 FDC drugs. Some might even be facing closure due to this indiscriminate return of medicines.


    The wholesalers are returning the non banned stock in the face of new arrivals in the market and their inability in selling the ones that are already on their shelves.The manufacturer's woe being that the non banned stocks returned to them were sold to the distributors based on their orders, reports Pharmabiz.


    According to sources in the pharma industry, inspectors were taking daily rounds of pharmacies instructing retail and wholesale stores to return all banned medication, and asking them for lists of pharmaceutical products already returned.


    “Without any proper reason, they are sending the sold products back to us because of poor sale. The banned combination brands are coming back every day. Along with them, the traders are sending the products which they do not want to market. What can we do, our go-downs are now full with the returned products which are not banned. Ours is also a business,” says Purushothaman Namboothiri, president of the Kerala Pharmaceutical Manufacturers Association. Namboothiri is of the opinion that the ban would completely destroy the contract manufacturing sector. Talking about banned products he said that all brands were being returned.


    In comparison with other states, the manufacturers felt that the 344 FDC drug ban would mark the end of pharma business community in Kerela. 'An overnight decision to ban decade old medicines has actually weakened the industry and is killing the small scale entrepreneurs,' said a manufacturer from Thrissur, a member of the KPMA.


    Kerala has a few well established pharmaceutical manufacturing companies under the SME sector; additionally an equal number of contract manufacturers. Seventy per cent of the total quantity of drugs marketed all over the state, and supplied in public and private health centres is manufactured and brought in from other states. A major portion of the medicines supplied by the state medical services corporation (KMSCL) are imported into the state after purchasing them from big players outside the state.


    344 FDC drug banBanned 344 FDC drugsKerala Pharmaceutical Manufacturers AssociationKerela Pharmaceutical industryKMSCLKPMAnon banned drugsPurushothaman NamboothiriSME sector
    Source : Inputs from India Blooms

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Geeta Sharma Sharma
    Geeta Sharma Sharma
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok